Intellectual Property

  AI is omnipresent nowadays in industries such as e-commerce, education and gaming, to name a few. One of its greatest strengths is that it can analyze huge amounts of data quickly and thoroughly, so it holds a lot of potential for healthcare diagnostics. As a result, AI can enable early disease detection and reduce the time required for analysis, thereby speeding up the workflow. Based on recent investments in healthcare, we identified 5 well-funded US startups known for their AI-powered medical diagnosis solutions from 2015-present. We used Assignee Quality Metrics in PatSeer to run a qualitative analysis on their patent portfolios. To get an idea of their background, please refer to the image given below. Learn more about these 5 medical care startups and the qualities of their patent portfolios here.

  Digital biomarker technology is used to gather behavioral, physiological data and diagnose illnesses. It is present in implantables, portables, digestibles and wearables. For example, devices like Oura rings, FitBits and Apple Watches use this technology. The market for digital biomarkers is estimated to reach approximately USD 24.5-25 billion by 2030, with a growth rate of  36-37%. To understand this technology better, we evaluated companies' patent filings in different countries during the last 10 years. Keywords related to digital biomarkers were used to create a search query in PatSeer along with the appropriate IPC and CPC classes. We found over 3000 patent families which were studied in more detail to understand the key companies and their filing trends in every country.    To know more about the key players and the patent landscape analysis of digital biomarker technology, go to: https://patseer.com/2022/05/digital-biomarker-technology-p...